Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease

J. A. Somarelli, A. Mesa, R. Rodriguez, R. Avellan, L. Martinez, Y. J. Zang, Eric L Greidinger, R. J. Herrera

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are autoimmune illnesses characterized by the presence of high titers of autoantibodies directed against a wide range of 'self ' antigens. Proteins of the U1 small nuclear ribonucleoprotein particle (U1 snRNP) are among the most immunogenic molecules in patients with SLE and MCTD. The recent release of a crystallized U1 snRNP provides a unique opportunity to evaluate the effects of tertiary and quaternary structures on autoantigenicity within the U1 snRNP. In the present study, an epitope map was created using the U1 snRNP crystal structure. A total of 15 peptides were tested in a cohort of 68 patients with SLE, 29 with MCTD and 26 healthy individuals and mapped onto the U1 snRNP structure. Antigenic sites were detected in a variety of structures and appear to include RNA binding domains, but mostly exclude regions necessary for protein-protein interactions. These data suggest that while some autoantibodies may target U1 snRNP proteins as monomers or apoptosis-induced, protease-digested fragments, others may recognize epitopes on assembled protein subcomplexes of the U1 snRNP. Although nearly all of the peptides are strong predictors of autoimmune illness, none were successful at distinguishing between SLE and MCTD. The antigenicity of some peptides significantly correlated with several clinical symptoms. This investigation implicitly highlights the complexities of autoimmune epitopes, and autoimmune illnesses in general, and demonstrates the variability of antigens in patient populations, all of which contribute to difficult clinical diagnoses. Lupus (2011) 20, 274-289.

Original languageEnglish
Pages (from-to)274-289
Number of pages16
JournalLupus
Volume20
Issue number3
DOIs
StatePublished - Mar 1 2011

Fingerprint

U1 Small Nuclear Ribonucleoproteins
Small Nuclear Ribonucleoproteins
Mixed Connective Tissue Disease
Epitope Mapping
Systemic Lupus Erythematosus
Epitopes
Proteins
Autoantibodies
Peptides
Autoantigens
Peptide Hydrolases
Apoptosis
Antigens

Keywords

  • autoantigen
  • autoimmune disease
  • pre-mRNA splicing
  • spliceosome

ASJC Scopus subject areas

  • Rheumatology

Cite this

Somarelli, J. A., Mesa, A., Rodriguez, R., Avellan, R., Martinez, L., Zang, Y. J., ... Herrera, R. J. (2011). Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease. Lupus, 20(3), 274-289. https://doi.org/10.1177/0961203310387180

Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease. / Somarelli, J. A.; Mesa, A.; Rodriguez, R.; Avellan, R.; Martinez, L.; Zang, Y. J.; Greidinger, Eric L; Herrera, R. J.

In: Lupus, Vol. 20, No. 3, 01.03.2011, p. 274-289.

Research output: Contribution to journalArticle

Somarelli, J. A. ; Mesa, A. ; Rodriguez, R. ; Avellan, R. ; Martinez, L. ; Zang, Y. J. ; Greidinger, Eric L ; Herrera, R. J. / Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease. In: Lupus. 2011 ; Vol. 20, No. 3. pp. 274-289.
@article{880e383e9d8f4310ae64c6b3578817cd,
title = "Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease",
abstract = "Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are autoimmune illnesses characterized by the presence of high titers of autoantibodies directed against a wide range of 'self ' antigens. Proteins of the U1 small nuclear ribonucleoprotein particle (U1 snRNP) are among the most immunogenic molecules in patients with SLE and MCTD. The recent release of a crystallized U1 snRNP provides a unique opportunity to evaluate the effects of tertiary and quaternary structures on autoantigenicity within the U1 snRNP. In the present study, an epitope map was created using the U1 snRNP crystal structure. A total of 15 peptides were tested in a cohort of 68 patients with SLE, 29 with MCTD and 26 healthy individuals and mapped onto the U1 snRNP structure. Antigenic sites were detected in a variety of structures and appear to include RNA binding domains, but mostly exclude regions necessary for protein-protein interactions. These data suggest that while some autoantibodies may target U1 snRNP proteins as monomers or apoptosis-induced, protease-digested fragments, others may recognize epitopes on assembled protein subcomplexes of the U1 snRNP. Although nearly all of the peptides are strong predictors of autoimmune illness, none were successful at distinguishing between SLE and MCTD. The antigenicity of some peptides significantly correlated with several clinical symptoms. This investigation implicitly highlights the complexities of autoimmune epitopes, and autoimmune illnesses in general, and demonstrates the variability of antigens in patient populations, all of which contribute to difficult clinical diagnoses. Lupus (2011) 20, 274-289.",
keywords = "autoantigen, autoimmune disease, pre-mRNA splicing, spliceosome",
author = "Somarelli, {J. A.} and A. Mesa and R. Rodriguez and R. Avellan and L. Martinez and Zang, {Y. J.} and Greidinger, {Eric L} and Herrera, {R. J.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1177/0961203310387180",
language = "English",
volume = "20",
pages = "274--289",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease

AU - Somarelli, J. A.

AU - Mesa, A.

AU - Rodriguez, R.

AU - Avellan, R.

AU - Martinez, L.

AU - Zang, Y. J.

AU - Greidinger, Eric L

AU - Herrera, R. J.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are autoimmune illnesses characterized by the presence of high titers of autoantibodies directed against a wide range of 'self ' antigens. Proteins of the U1 small nuclear ribonucleoprotein particle (U1 snRNP) are among the most immunogenic molecules in patients with SLE and MCTD. The recent release of a crystallized U1 snRNP provides a unique opportunity to evaluate the effects of tertiary and quaternary structures on autoantigenicity within the U1 snRNP. In the present study, an epitope map was created using the U1 snRNP crystal structure. A total of 15 peptides were tested in a cohort of 68 patients with SLE, 29 with MCTD and 26 healthy individuals and mapped onto the U1 snRNP structure. Antigenic sites were detected in a variety of structures and appear to include RNA binding domains, but mostly exclude regions necessary for protein-protein interactions. These data suggest that while some autoantibodies may target U1 snRNP proteins as monomers or apoptosis-induced, protease-digested fragments, others may recognize epitopes on assembled protein subcomplexes of the U1 snRNP. Although nearly all of the peptides are strong predictors of autoimmune illness, none were successful at distinguishing between SLE and MCTD. The antigenicity of some peptides significantly correlated with several clinical symptoms. This investigation implicitly highlights the complexities of autoimmune epitopes, and autoimmune illnesses in general, and demonstrates the variability of antigens in patient populations, all of which contribute to difficult clinical diagnoses. Lupus (2011) 20, 274-289.

AB - Systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD) are autoimmune illnesses characterized by the presence of high titers of autoantibodies directed against a wide range of 'self ' antigens. Proteins of the U1 small nuclear ribonucleoprotein particle (U1 snRNP) are among the most immunogenic molecules in patients with SLE and MCTD. The recent release of a crystallized U1 snRNP provides a unique opportunity to evaluate the effects of tertiary and quaternary structures on autoantigenicity within the U1 snRNP. In the present study, an epitope map was created using the U1 snRNP crystal structure. A total of 15 peptides were tested in a cohort of 68 patients with SLE, 29 with MCTD and 26 healthy individuals and mapped onto the U1 snRNP structure. Antigenic sites were detected in a variety of structures and appear to include RNA binding domains, but mostly exclude regions necessary for protein-protein interactions. These data suggest that while some autoantibodies may target U1 snRNP proteins as monomers or apoptosis-induced, protease-digested fragments, others may recognize epitopes on assembled protein subcomplexes of the U1 snRNP. Although nearly all of the peptides are strong predictors of autoimmune illness, none were successful at distinguishing between SLE and MCTD. The antigenicity of some peptides significantly correlated with several clinical symptoms. This investigation implicitly highlights the complexities of autoimmune epitopes, and autoimmune illnesses in general, and demonstrates the variability of antigens in patient populations, all of which contribute to difficult clinical diagnoses. Lupus (2011) 20, 274-289.

KW - autoantigen

KW - autoimmune disease

KW - pre-mRNA splicing

KW - spliceosome

UR - http://www.scopus.com/inward/record.url?scp=79958716881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958716881&partnerID=8YFLogxK

U2 - 10.1177/0961203310387180

DO - 10.1177/0961203310387180

M3 - Article

VL - 20

SP - 274

EP - 289

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 3

ER -